Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Nautilus Biotechnology (NASDAQ: NAUT) will report fourth quarter and full year 2025 financial results before market open on Thursday, February 26, 2026.
Rhea-AI Summary
Nautilus Biotechnology (NASDAQ: NAUT) will report fourth quarter and full year 2025 financial results before market open on Thursday, February 26, 2026. Management will host a webcast and conference call to discuss results, business developments, and outlook.
Live audio will be available on the company’s Investors webpage at www.nautilus.bio.
Positive
- None.
Negative
- None.
Details
News Market Reaction – NAUT
In the Feb 5 session, NAUT declined 2.88%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Earnings period
- Fourth quarter and full year 2025
- Period for upcoming results
- Earnings date
- February 26, 2026
- Scheduled results release before market open
- Conference time PT
- 5:30 a.m. Pacific Time
- Start of management webcast
- Conference time ET
- 8:30 a.m. Eastern Time
- Start of management webcast
Historical Context
-
Parkinson’s biomarker collaboration backed by $1.6 million MJFF grant.
-
Launch of early access program for single-molecule proteomics tau assay.
-
First external field evaluation unit installed and tested with reproducible data.
-
Q3 2025 results with reduced expenses and substantial cash balance reported.
-
Announcement of timing for Q3 2025 earnings release and webcast details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
single-molecule protein analysis platform medical
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
SEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the fourth quarter and full year 2025 before market open on Thursday, February 26, 2026.
The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.